한국어
English
日本語
中文(简体)Prezcobix Tablets
288mg
Tablet · Prescription medication · Combination
Korea Janssen Co., Ltd.
Cobicistat Silica is an excipient that enhances the effectiveness of antiretroviral agents.
MFDS ingredient code M115484
Cobicistat Silica is used in conjunction with antiretroviral agents to increase the drug concentration in the body. It is primarily included in HIV medications, inhibiting drug metabolism to enhance therapeutic effects. This component is a combined form of silica and cobicistat, assisting in drug stability and absorption.
Cobicistat Silica inhibits enzymes in the liver that break down drugs, slowing the degradation of antiretroviral agents. As a result, the drug remains in the body longer, enhancing its effects. In other words, it increases the blood concentration of the drug to improve therapeutic effectiveness.
Approved uses differ by product. Check each product's information for its actual use.
Unlike simple silica, Cobicistat Silica contains a combination of cobicistat, which provides a drug metabolism inhibiting function. This distinguishes it from standard silica and specializes in enhancing the effects of antiretroviral agents.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.